From Research Excellence to MedTech Impact.
A high-velocity accelerator for startups building medical devices, diagnostics, and healthcare technology for India.
Bridging the gap between laboratory research and clinical adoption.
Most Indian MedTech startups stall not on scientific engineering, but on the complex hurdles that follow: clinical trial access, CDSCO device classification, ISO 13485 audits, hospital procurement inertia, and seed funding. This programme unites three formidable forces to systematically dismantle those barriers.
India Accelerator
India's premier seed accelerator & GAN partner with 250+ startups. IA injects market access, pricing discipline, corporate hospital tie-ups, regulatory advisory, and a dedicated healthcare angel syndicate.
- 14+ HealthTech portfolio investments
- Leaders from Medanta, Fortis & NATHEALTH
TBI-GEU
DST-supported deep-tech incubation ecosystem with state-of-the-art cleanrooms, 3D additive manufacturing, CNC machining, medical electronics testing benches, and faculty clinician partnerships.
- Full prototyping and test lab access
- Hospital ethics committee clearance linkages
The Startup Cohort
A curated startup cohort of early-stage founders with validated lab prototypes (TRL 4+), patents, and proprietary hardware/AI architectures ready to transition from benchwork to hospital clinical adoption.
- 1:1 individualized roadmap and sprint goals
- Zero cohort fee and no mandatory equity
Bench to Bedside: Building for Bharat and the World.
India is at an inflection point. Domestic healthcare expenditure is surging, government PLI schemes and MedTech parks are providing manufacturing tailwinds, and over 70% of medical devices remain imported.
The infrastructure, capital and network your startup needs.
Every component of this accelerator is tailored specifically to medical technology, clinical pathways, and hardware development timelines.
Research labs, technical infrastructure and testing facilities
Full access to Graphic Era's high-spec prototyping labs, cleanroom facilities, 3D additive manufacturing, CNC machining, and biomedical electronics testing benches.
Collaborative R&D and technology validation
Structured R&D collaboration with university faculty, clinical researchers, and hospital networks for in-depth laboratory testing and clinical proof-of-concept validation.
Technical feedback and product development support
Hands-on engineering teardowns, design-for-manufacturing (DFM), embedded hardware optimization, and device safety compliance guidance from seasoned biomedical engineers.
Mentors, investors and subject matter experts
Direct 1:1 mentorship from veteran healthcare founders, hospital clinical directors, former CDSCO technical panelists, and life-sciences venture capital partners.
Business model refinement, pitch preparation and market access support
Institutional hospital procurement strategies, unit economics modeling, pilot design, and commercial distribution pipelines through India Accelerator.
Investor readiness support, then Demo Day in front of investors and industry experts
Battle-tested data room and pitch deck coaching culminating in a national Demo Day in April 2027 before 50+ leading healthcare angels, syndicates, and seed funds.
Internship and talent access from GEU students
Direct recruitment pipelines to hire high-caliber student interns and research fellows across biomedical engineering, electronics, computer science, and healthcare management.
Six frontiers of medical innovation.
We back founders building defensible technologies that improve clinical outcomes, reduce care delivery costs, or widen geographic access across Tier-2/3 India and global emerging markets.
Point-of-Care Diagnostics
Rapid bedside diagnostics, automated screening kits, microfluidics, biomarker detection, and portable testing devices engineered for decentralized clinical and primary care settings.
Medical Imaging
Portable ultrasound, AI-enhanced radiology scanners, compact handheld optical devices, and digital pathology tools delivering high-resolution diagnostics at accessible costs.
Patient Monitoring
Continuous ICU and bedside vitals tracking, multiparameter patient monitors, automated clinical alerting systems, and wireless telemetry reducing healthcare provider burden.
Surgical Devices
Minimally invasive instruments, precision electrosurgical tools, targeted ablation systems, and endoscopic hardware delivering higher surgical accuracy and safety.
Implants and Prosthetics
Patient-specific 3D-printed orthopedic and dental implants, biocompatible surface coatings, bioresorbable fixation hardware, and active motorized prosthetics.
Wearable Health Tech
Continuous biometric telemetry wearables, non-invasive home health tracking sensors, early chronic disease detection patches, and connected preventive health devices.
Eligibility criteria for the 2027 cohort.
We focus on deep-tech medical innovators who have crossed the early exploratory phase and are ready to tackle commercialization, validation, and regulatory milestones.
MVP or Early Traction
Early-stage startups with a functional minimum viable product (MVP), benchtop prototype, or early clinical and market traction (TRL 4+).
Registered Indian Entity
Pvt. Ltd. registered in India, not older than 10 years, with annual turnover not exceeding ₹100 crore (or research teams committed to incorporating upon selection).
MedTech Aligned
Startups building medical devices, diagnostics, implants, assistive technology, ICU/hospital equipment, or software with an explicit medical purpose.
Am I eligible for this cohort?
Do you have a working prototype, benchtop MVP, or early market/clinical traction?
Is your venture an Indian entity (<10 years, turnover <₹100 Cr) or committed to incorporating upon selection?
Is your solution in MedTech (devices, diagnostics, equipment, implants, or clinical medical software)?
Answer all 3 questions above to check your qualification status instantly.
A 22-week roadmap from prototype to commercial pilot.
Clear timelines and structured deliverables ensure every participating founder exits with clinical validation protocols, CDSCO regulatory clarity, and investor readiness.
National call for applications opens across research universities, incubators, hospital innovation cells, and healthcare founder networks.
Evaluation committee conducts technical screening, shortlists top 25 teams for pitch juries, and finalizes the curated startup cohort.
22-week acceleration launches: clinical trial design, product teardowns, CDSCO roadmap drafting, and 1:1 mentor assignments.
Startups pitch live to healthcare seed VCs, family offices, angel syndicates, and hospital network procurement leaders.
Cohort Specifications & Key Information
Learn from leaders who have built, scaled and funded MedTech.
Our mentor network brings together leaders from NATHEALTH, Fortis, Suburban Diagnostics, Eight Roads, Medicom, and premier medical institutes.
Anjan Bose
Former Founding Secretary General, NATHEALTH
Former President, Philips Healthcare and Consumer Lifestyle.
Mukul Bagga
MD, Medicom Healthcare India
Previously Novartis, Quest Diagnostics, J&J and Ranbaxy.
Dr. Virender Sangwan
Director, Innovation, Dr. Shroff's Charity Eye Hospital
Distinguished clinical innovator and researcher. Previously L V Prasad Eye Institute.
Deepak Naik
MD, Health N'U' Therapeutics
Previously Ranbaxy, Eisai Pharmaceuticals and Wockhardt.
Dr. Sanjay Arora
Founder, Suburban Diagnostics
Pioneering clinical diagnostics entrepreneur and healthcare leader across India.
Vijayasimha Ajarananda
CEO, Audicor Cardiometrics
Expertise in cardiac diagnostics, physiological monitoring devices, and biomedical engineering.
Dr. Shikha Dhawan
Director, Programs, SHARE India
Public health specialist spearheading multi-institutional healthcare implementation programs.
Deepak Kanvinde
Venture Partner, Eight Roads
Venture investor with extensive experience in scaling deep-tech healthcare and life-sciences.
Dr. Nita Roy
Consultant, Advanced Research R&I, L'Oreal India
Specialist in applied biotechnology, biomaterials research, and advanced formulation R&D.
Dr. Rahul Bhargava
Director and Head, Hematology and Stem Cell Transplant
Fortis Healthcare. Pioneer in clinical stem cell protocols and hospital healthcare innovation.
Mark Waechter
Chief Evangelist, Future4Health
International digital health visionary, ecosystem strategist, and venture mentor.
Vikas Malhotra
Director-Professor and Head, Chairman IT
Dr. Baba Saheb Ambedkar Medical College and Hospital. Leader in clinical IT and medical infrastructure.
Clear milestones. Not just classroom lectures.
Every sprint is anchored around tangible deliverables that de-risk your technology, satisfy regulatory bodies, and prepare your startup for institutional seed rounds.
Clinical Trial Protocol Ready
Verified ethical committee submission documentation, clinical trial registry protocol, and identified hospital pilot partners.
CDSCO Regulatory Dossier
Device classification mapped, essential principles checklist completed, and testing laboratory schedule locked.
Production BOM & Design Freeze
Industrial design freeze, production-grade Bill of Materials (BOM), and certified contract manufacturer pipeline in place.
ABDM & Digital Interoperability
Architecture aligned with Ayushman Bharat Digital Mission (ABDM) standards for patient health records and EHR connectivity.
Commercial Financial Model
Validated hospital capex/opex unit economics, insurance/reimbursement roadmap, and institutional pricing structure.
Investor-Grade Demo Pitch
Battle-tested 5-minute pitch deck, data room, and cap-table ready for term sheet negotiations on Demo Day.
Demo Day · April 2027
Pitch live to over 50 healthcare-focused angel investors, seed venture capital funds, corporate venture arms, and hospital procurement directors actively seeking commercial pilots and investment opportunities.
Frequently Asked Questions
Everything you need to know about eligibility, program commitments, equity, funding, and IP ownership.
Two powerhouses united for Indian MedTech.
Combining academic research excellence and hospital linkages with commercial acceleration rigor and venture capital access.
TBI-GEU
Technology Business Incubator (TBI) at Graphic Era (Deemed to be University), Dehradun, is supported by DST, Govt. of India. TBI-GEU nurtures deep-tech, electronics, AI, and healthcare innovations with state-of-the-art cleanrooms, prototyping labs, clinical trial hospital tie-ups, and pre-seed funding.
India Accelerator
India Accelerator is the country's premier seed accelerator, partnered with the Global Accelerator Network (GAN). With 250+ portfolio companies and 14+ dedicated healthcare investments across maternal care, genomics, and diagnostics, IA brings commercial mentorship from leaders at Medanta, Fortis, and NATHEALTH.




